drugset / Trial / NCT05172934
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial
NaSingle-groupOpen-labelTreatment
Summary
Prospective, single center, non-randomized, pilot study to assess the feasibility of IA TNK following standard of care mechanical thrombectomy (MT) in patients with AIS. Participants will receive IA TNK after achieving mTICI 2b or 2c reperfusion with standard of care MT. Patients enrolled into the study will be followed for 3 months after treatment with IA TNK.
Timeline
- Start
- 2022-03-15
- Primary completion
- 2023-09-12
- Completion
- 2023-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenecteplase | Protein / enzyme biologic | 4.5 mg | Other |